Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21321603rdf:typepubmed:Citationlld:pubmed
pubmed-article:21321603lifeskim:mentionsumls-concept:C1882071lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C1335877lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C0235280lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:21321603lifeskim:mentionsumls-concept:C1314939lld:lifeskim
pubmed-article:21321603pubmed:issue6lld:pubmed
pubmed-article:21321603pubmed:dateCreated2011-6-2lld:pubmed
pubmed-article:21321603pubmed:abstractTextWe herein investigated the role of the STAT signaling cascade in the production of pro-inflammatory cytokines and cisplatin ototoxicity. A significant hearing impairment caused by cisplatin injection was observed in Balb/c (wild type, WT) and STAT4(-/-), but not in STAT6(-/-) mice. Moreover, the expression levels of the protein and mRNA of pro-inflammatory cytokines, including TNF-?, IL-1?, and IL-6, were markedly increased in the serum and cochlea of WT and STAT4(-/-), but not STAT6(-/-) mice. Organotypic culture revealed that the shape of stereocilia bundles and arrays of sensory hair cell layers in the organ of Corti from STAT6(-/-) mice were intact after treatment with cisplatin, whereas those from WT and STAT4(-/-) mice were highly distorted and disarrayed after the treatment. Cisplatin induced the phosphorylation of STAT6 in HEI-OC1 auditory cells, and the knockdown of STAT6 by STAT6-specific siRNA significantly protected HEI-OC1 auditory cells from cisplatin-induced cell death and inhibited pro-inflammatory cytokine production. We further demonstrated that IL-4 and IL-13 induced by cisplatin modulated the phosphorylation of STAT6 by binding with IL-4 receptor alpha and IL-13R?1. These findings suggest that STAT6 signaling plays a pivotal role in cisplatin-mediated pro-inflammatory cytokine production and ototoxicity.lld:pubmed
pubmed-article:21321603pubmed:languageenglld:pubmed
pubmed-article:21321603pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:citationSubsetIMlld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21321603pubmed:statusMEDLINElld:pubmed
pubmed-article:21321603pubmed:monthJunlld:pubmed
pubmed-article:21321603pubmed:issn1748-7838lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:LimDavid JDJlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:LeeSang-HeonS...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:SoHong-SeobHSlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:ParkRaekilRlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:OhGi-SuGSlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:MoonSung-Kyun...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:ParkSung-JooS...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:ParkChannyClld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:KimHyung-JinH...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:YouYong-OukYOlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:ChungSang-You...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:SongJehoJlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:LeeJeong-HanJ...lld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:LyuAh-RaARlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:JiHye-MinHMlld:pubmed
pubmed-article:21321603pubmed:authorpubmed-author:SulJeong-DugJ...lld:pubmed
pubmed-article:21321603pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21321603pubmed:volume21lld:pubmed
pubmed-article:21321603pubmed:ownerNLMlld:pubmed
pubmed-article:21321603pubmed:authorsCompleteYlld:pubmed
pubmed-article:21321603pubmed:pagination944-56lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:meshHeadingpubmed-meshheading:21321603...lld:pubmed
pubmed-article:21321603pubmed:year2011lld:pubmed
pubmed-article:21321603pubmed:articleTitleCisplatin ototoxicity involves cytokines and STAT6 signaling network.lld:pubmed
pubmed-article:21321603pubmed:affiliationVestibulocochlear Research Center & Department of Microbiology, Wonkwang University, Iksan, Jeonbuk 570-749, Korea.lld:pubmed
pubmed-article:21321603pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21321603pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed